Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD
|
|
- Bryce Thomas
- 5 years ago
- Views:
Transcription
1 Co-Occurring Mental Health and Substance Use Disorders DATE: 4/17/18 PRESENTED BY: John Mahan, MD
2 Disclosure Information Speaker: John Mahan, MD has nothing to disclose Planning Committee: The members of the planning committee (Jessica Gregg, Todd Korthuis, Melissa Weimer, John Mahan, Laura Heesacker, O Nesha Cochran, and Chris Colasurdo) have nothing to disclose.
3 Learning Objectives Understand that psychiatric symptoms occur during substance intoxication and withdrawal Learn more about substance-induced psychiatric syndromes (as distinct from intoxication and withdrawal) Introduce Hallucinogen Persisting Perception Disorder Discuss how to differentiate between non-substancerelated psychiatric illness from substance-related syndromes Discuss Dual Diagnosis treatment principles
4 Unfortunately A comprehensive review of non-substance-related psychiatric syndromes is beyond the scope of the lecture. But there is likely an ECHO for that.
5 Nomenclature The terms Co-occurring Disorders, or Dual Diagnosis, refer to the co-occurrence of at least two psychiatric diagnoses, one of which relates to substance use.
6 Co-occurring Disorders Co-occur, indeed. The stress-diathesis model postulates that there are genetic underpinnings (diathesis), as well as acquired stresses (biological, environmental, psychological, etc) that conspire to cause mental illness. Diatheses for psychiatric syndromes and substance use disorders may co-occur more frequently than chance The same stresses may act towards the evolution of both psychiatric syndromes and substance use disorders.
7 Co-occurring Disorders Psychiatric symptoms may increase the likelihood that a substance is first used, or the degree to which it is reinforcing (the self-medication hypothesis) Substance use itself may act as an inciting stress Adolescent cannabis use (though neither necessary nor sufficient alone) is one of the few known component causes of schizophrenia! Trauma and altered life circumstances may occur during substance use, precipitating psychiatric disorders related to post-traumatic stress, depression, anxiety, sleep-wake, etc (really any disorder)
8 Epidemiology (brief) Epidemiologic Catchment Area study (Regier et al 1990): Lifetime prevalence of any SUD in a community sample was 16.7% Prevalence of any SUD in patients with a history of mental illness was 29% In those with history of a SUD, more than half had a lifetime history of a mental disorder and had more than four times the risk (OR=4.5) of having a mental disorder compared to those with no history of SUD
9 Epidemiology (brief) National Comorbidity Survey (Kessler et al 1996): Odds Ratio of 2.4 for comorbidity between any lifetime mental illness and any lifetime SUD. 50.8% of individuals with a history of mental illness had a history of a SUD 51.4% of those with a history of a SUD had a history of a mental disorder in their lifetime
10 Epidemiology (brief) Prevalence of Co-Occurring Mental Health and Substance Use Disorders (Hendrickson 2006): 3%-4% in the community 40%-60% in mental health treatment settings 50%-60% in substance abuse treatment settings
11 Psychiatric Symptoms and Diagnosis Psychiatric symptoms in isolation are not rare, and occur both with and without other symptoms that could indicate the presence of a full psychiatric syndrome or diagnosis. Common examples are irritability, insomnia, anger, low energy, worry, decreased appetite, and poor concentration (more to follow).
12 Psychiatric Symptoms and Diagnosis To represent a psychiatric diagnosis, these symptoms should: Occur in a recognized grouping (syndrome) Persist for a specified duration Cause clinically significant distress or impairment in social, occupational, or other important areas of functioning Not be attributable to another medical condition Not be better explained by another mental disorder
13 Objectives Understand that psychiatric symptoms occur during substance intoxication and withdrawal Learn more about substance-induced psychiatric syndromes (as distinct from intoxication and withdrawal) Introduce Hallucinogen Persisting Perception Disorder Discuss how to differentiate between non-substancerelated psychiatric illness from substance-related syndromes Discuss Dual Diagnosis treatment principles
14 Psychiatric Symptoms in Intoxication (during or shortly after use) Clinically significant problematic behavioral or psychological changes that developed during, or shortly after, [substance] ingestion. (DSM5 Criterion B of an intoxication syndrome)
15 Psychiatric Symptoms in Intoxication (during or shortly after use) What follows is a non-exhaustive list of psychiatric symptoms mentioned in DSM5 diagnostic criteria that occur during substance intoxication syndromes.
16 Psychiatric Symptoms in Intoxication (during or shortly after use) Alcohol: hypersexuality, aggression, mood lability, poor judgment, impaired attention Caffeine: restlessness, nervousness, insomnia, rambling thought/speech, inexhaustibility Cannabis: euphoria, anxiety, sensation of slowed time, poor judgment, social withdrawal, perceptual disturbances PCP: aggression, impulsivity, psychomotor agitation, poor judgment
17 Psychiatric Symptoms in Intoxication (during or shortly after use) Other Hallucinogens: anxiety, depression, ideas of reference, fear, paranoia, poor judgment, depersonalization, derealization, illusions, hallucinations Inhalants: aggression, apathy, poor judgment, lethargy, euphoria Opioids: euphoria, apathy, dysphoria, psychomotor agitation or depression, poor judgment, poor concentration, perceptual disturbances
18 Psychiatric Symptoms in Intoxication (during or shortly after use) Sedatives: hypersexuality, aggression, mood lability, poor judgment, poor concentration Stimulants: euphoria, flattened affect, hypersocial, social withdrawal, hypervigilence, interpersonal sensitivity, anxiety, tension, anger, stereotypies, poor judgment, psychomotor agitation or retardation, perceptual disturbances (No diagnosis of tobacco intoxication in DSM5)
19 Psychiatric Symptoms in Withdrawal (within hours or days of cessation/reduction of sufficient use) Alcohol: Insomnia, anxiety, psychomotor agitation, perceptual disturbances Caffeine: low energy, dysphoria, depressed mood, irritability, poor concentration Cannabis: irritability, anger, aggression, nervousness, anxiety, insomnia, nightmares, decreased appetite, restlessness, depressed mood (No diagnoses of Hallucinogen or Inhalant Withdrawal in DSM5)
20 Psychiatric Symptoms in Withdrawal (within hours or days of cessation/reduction of sufficient use) Opioids: dysphoria, insomnia, *perceptual disturbances (methadone, NMDA dysregulation?) Sedatives: insomnia, transitory perceptual disturbances, anxiety, psychomotor agitation, Stimulants: dysphoria (required), low energy, nightmares, insomnia, hypersomnia, increased appetite, psychomotor retardation or agitation Tobacco: irritability, frustration, anger, anxiety, poor concentration, increased appetite, restlessness, depressed mood, insomnia
21 Objectives Understand that psychiatric symptoms occur during substance intoxication and withdrawal Learn more about substance-induced psychiatric syndromes (as distinct from intoxication and withdrawal) Introduce Hallucinogen Persisting Perception Disorder Discuss how to differentiate between non-substancerelated psychiatric illness from substance-related syndromes Discuss Dual Diagnosis treatment principles
22 Substance-Induced Disorders Diagnosed instead of substance intoxication or withdrawal only when the symptoms are sufficiently severe to warrant independent clinical attention For example, Methamphetamine Induced Psychosis (may take months to clear) Cocaine induced bipolar disorder (mania that resolves with sustained sobriety) Alcohol induced depressive disorder Cannabis induced anxiety disorder Caffeine induced anxiety disorder Caffeine induced sleep disorder
23 Diagnoses Associated with Substance Use (DSM5)
24 Objectives Understand that psychiatric symptoms occur during substance intoxication and withdrawal Learn more about substance-induced psychiatric syndromes (as distinct from intoxication and withdrawal) Introduce Hallucinogen Persisting Perception Disorder Discuss how to differentiate between non-substancerelated psychiatric illness from substance-related syndromes Discuss Dual Diagnosis treatment principles
25 Hallucinogen Persisting Perceptual DO Following cessation, re-experiencing (when sober) one or more of the perceptual symptoms that were experienced during intoxication: Geometric hallucinations False perceptions of movement in the periphery Flashes of color Intensified colors Trails of images of moving objects Positive afterimages Halos around objects, Macropsia Micropsia
26 Hallucinogen Persisting Perceptual DO Not attributable to another medical condition like Anatomical lesions of the brain Infections of the brain Visual epilepsy
27 Hallucinogen Persisting Perceptual DO Not better explained by another mental disorder like Delirium Major Neurocognitive Disorder Schizophrenia (or by) Hypnopompic hallucinations
28 Hallucinogen Persisting Perceptual DO Reality testing (insight into their illusory nature) remains intact Usually resolves within 1-2 years of last use, but may be triggered by use of other substances or in adaptation to dark environments Thought to occur in 4.2% of people who have used a hallucinogen
29 Objectives Understand that psychiatric symptoms occur during substance intoxication and withdrawal Learn more about substance-induced psychiatric syndromes (as distinct from intoxication and withdrawal) Introduce Hallucinogen Persisting Perception Disorder Discuss how to differentiate between non-substancerelated psychiatric illness from substance-related syndromes Discuss Dual Diagnosis treatment principles
30 Differential Diagnosis Confusion is a common problem in multiply diagnosed patients. Is impairment Due to substance use alone? Due to mental illness alone? Due to a complex interaction between substance use, mental illness, and medical illness? Due to other factors? Co-existing cognitive impairment is also frustrating in the diagnostic process.
31 Differential Diagnosis Common pitfalls (Galanter et al 2015): Using a single assessment (especially in the acute setting Using a single source of information Underdiagnosis (etiological, most elegant solution) vs Overdiagnosis (suggested by epidemiological data)
32 Differential Diagnosis Optimally (Galanter et al 2015): Use serial, longitudinal assessments Can control for a variable, like abstinence Use multiple sources of data Interview, pt self-report, collateral information, physical examination, laboratory tests, etc
33 Overdiagnosis vs. Underdiagnosis (Galanter et al 2015) Assuming that the most elegant solution, an etiological diagnosis (eg psychiatric symptoms are caused by substance use) is correct can delay needed treatment for mental illness that may be worsening outcomes for treatment of co-occurring SUD. Depending on where you encounter a patient, diagnosing multiple non-etiological co-occurring diagnoses may be correct more often, given the epidemiologic data discussed earlier (co-occurring illness in at least half of all patients in either mental health or substance abuse treatment systems). Conversely, overdiagnosis can lead to harmful exposure to long-term treatment.
34 Differential Diagnosis To differentiate etiological (substance-induced) diagnoses from co-occurring mental health and substance use diagnoses: 1) Understand which substances are capable of causing which substance-induced disorders
35 Differential Diagnosis (DSM5)
36 Differential Diagnosis To differentiate etiological (substance-induced) diagnoses from co-occurring mental health and substance use diagnoses: 2) Consider the typology of symptoms Most substances cause only positive symptoms of psychosis, where NMDA antagonists (PCP/ketamine/dextromethorphan-dextrorphan) can induce positive, negative, and cognitive symptoms of psychosis (like schizophrenia)
37 Differential Diagnosis To differentiate etiological (substance-induced) diagnoses from co-occurring mental health and substance use diagnoses: 3) Establish a timeline of when the psychiatric symptoms occurred in relation to the onset of substance use Age at first use Does the severity of symptoms vary with intoxication or withdrawal, or is it rather constant? Consider family history
38 Differential Diagnosis To differentiate etiological (substance-induced) diagnoses from co-occurring mental health and substance use diagnoses: 4) Understand the appropriate mount of abstinence required before substance-induced symptoms typically resolve Do not diagnose primary mental illness due to symptoms only present during intoxication or withdrawal For most substances, wait for 1 month of abstinence before differentially diagnosing the mental illness Methamphetamine-, Cathinone-, Cannabinoid-, and chronic Alcohol-induced psychoses may persist for several months post cessation.
39 Differential Diagnosis (summary) To differentiate etiological (substance-induced) diagnoses from co-occurring mental health and substance use diagnoses: 1) Understand which substances are capable of causing which substance-induced disorders 2) Consider the typology of symptoms 3) Establish a timeline of when the psychiatric symptoms occurred in relation to the onset of substance use 4) Understand the appropriate mount of abstinence required before substance-induced symptoms typically resolve
40 Learning Objectives Understand that psychiatric symptoms occur during substance intoxication and withdrawal Learn more about substance-induced psychiatric syndromes (as distinct from intoxication and withdrawal) Introduce Hallucinogen Persisting Perception Disorder Discuss how to differentiate between non-substancerelated psychiatric illness from substance-related syndromes Discuss Dual Diagnosis treatment principles
41 Treatment (briefly) Let assessment and diagnosis guide your referral Co-occurring mental health and substance use diagnoses are optimally treated in a co-occurring capable setting when capable (prevent pinball) Agencies are becoming increasingly more co-occurring capable Patient-centered treatment and individualization is the guiding principle in dual diagnosis care Wrap-around community care vs residential Individual therapy vs group-focused care
42 Treatment (briefly) Psychopharmacotherapy (Galanter et al 2015): Aim for Acute stabilization of mental health and SUD symptoms Remission of mental health and SUD symptoms Avoid addictive medications (remembering that all medications are abusable, but not necessarily addictive) Use psychiatric medications with broad spectrum of activity for multiple disorders Bupropion for depression, ADHD (off label), and tobacco UD Clozapine for schizophrenia and SUD (off label) Taper medications when remission of substance-induced psychiatric symptoms is achieved to limit long-term harm
43 References American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5 th Edition. Washington, DC, American Psychiatric Association, 2013 Avery JD, Barnhill JW: Co-occurring Mental Illness and Substance Use Disorders; a guide to diagnosis and treatment. Arlington, VA, American Psychiatric Association Publishing, 2018 Compton, MT: Marijuana and Mental Health. Arlington, VA, American Psychiatric Association Publishing, 2016 Galanter M, Kleber HD, Brady KT: The American Psychiatric Publishing Textbook of substance abuse treatment, 5 th Edition. Arlington, VA, American Psychiatric Publishing, 2015 Hendrickson EL: Designing, Implementing, and Managing Treatment Services for Individuals with Co-Occurring Mental Health and Substance Use Disorders: Blueprints for Action. Binghamton, New York, Haworth, 2006 Kessler RC, Nelson CB, McGonagle KA, et al: The epidemiology of Co-occurring addictive and mental health disorders: implications for prevention and service utilization. Am J Orthopsychiatry 66(1):17-31, Regier DA, Farmer ME, Rae DS, et al: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19): ,
Co-Occurring Mental Health and Substance Use Disorders. DATE: 11/14/2017 PRESENTED BY: John Mahan, MD
Co-Occurring Mental Health and Substance Use Disorders DATE: 11/14/2017 PRESENTED BY: John Mahan, MD Disclosure Information Speaker: John Mahan, MD has nothing to disclose Learning Objectives Understand
More informationSubstance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
More informationDSM-5 UPDATE. Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
DSM-5 UPDATE Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION October 2017 DSM-5 Update October 2017 Supplement to Diagnostic and Statistical Manual of Mental Disorders,
More informationsubstance use and mental disorders: one, the other, or both?
substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015
More informationMOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS
MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types
More informationConcurrent Disorders
Concurrent Disorders Dr. Christy Sutherland MD CCFP dipabam Medical Director, PHS Community Services Methadone/Buprenorphine 101 Workshop April 1, 2017 Overview Introduction Epidemiology Treatment Principles
More informationSubstance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationThe Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal
More informationComorbidity With Substance Abuse P a g e 1
Comorbidity With Substance Abuse P a g e 1 Comorbidity With Substance Abuse Introduction This interesting session provided an overview of recent findings in the diagnosis and treatment of several psychiatric
More informationPSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW
TMH Professionals, LLC, American College of Psychotherapy & LPCA present PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW Module 4: Substance Use Disorders, Impulse Control
More informationCANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS
CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners, Albany, NY Assistant Professor of Medicine,
More informationPSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH
PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH OVERVIEW: PSYCHIATRIC DISORDERS Mood Disorders Anxiety Disorders Psychotic Disorders Personality Disorders PTSD Eating Disorders EXAMPLE What is the diagnosis?
More informationRunning head: DEPRESSIVE DISORDERS 1
Running head: DEPRESSIVE DISORDERS 1 Depressive Disorders: DSM-5 Name: Institution: DEPRESSIVE DISORDERS 2 Abstract The 2013 update to DSM-5 saw revisions of the psychiatric nomenclature, diagnostic criteria,
More information7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER ELEVEN CHAPTER OUTLINE. Substance Use Disorders. Oltmanns and Emery
ABNORMAL PSYCHOLOGY SEVENTH EDITION Oltmanns and Emery PowerPoint Presentations Prepared by: Ashlea R. Smith, Ph.D. This multimedia and its contents are protected under copyright law. The following are
More informationMental Disorders with Associated Harmful Behavior and Substance-Related Disorders
Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders Kishore Desagani, MD General Adult and Forensic Psychiatrist Consultant Psychiatrist Medical Assessment and Policy Team
More informationMENTAL HEALTH AND MENTAL ILLNESS: OUR JOURNEY ACROSS THE CONTINUUM LLI PROGRAM OCTOBER 5, 2018 VIRGINIA F. RIGGS MS, MSN, RN
MENTAL HEALTH AND MENTAL ILLNESS: OUR JOURNEY ACROSS THE CONTINUUM LLI PROGRAM OCTOBER 5, 2018 VIRGINIA F. RIGGS MS, MSN, RN OBJECTIVES: Focus on a continuum from mental health to mental illness Examine
More information*Many of these DSM 5 Diagnoses might also be used to argue for eligibility using Other Health Impaired Criteria
Handout 2: DSM 5 Diagnoses that May be Associated with One or More of the Five ED Characteristics* 1. An inability to learn that cannot be explained by intellectual, sensory, or health factors. a) Selective
More informationRates of Co-Occurring Disorders Among Youth. Working with Adolescents with Substance Use Disorders
1 Working with Adolescents with Substance Use Disorders Michael S. Levy, Ph.D. CAB Health & Recovery Services, Inc. Health and Education Services 8% of 12-17 year old youth have substance abuse or dependence
More informationPSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL
PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL OVERVIEW What are Psychological Disorders? Anxiety Disorders, OCD, and PTSD Substance Use and Addictive Disorders Mood Disorders Schizophrenia Additional
More informationPharmacological Treatments for Tobacco Users with Behavioral Health Conditions
Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures
More informationPrimary Care: Referring to Psychiatry
Primary Care: Referring to Psychiatry Carol Capitano, PhD, APRN-BC Assistant Professor, Clinical Educator University of New Mexico College of Nursing University of New Mexico Psychiatric Center Objectives
More informationMarijuana. Marijuana (Cannabis Use Disorder) Learning Goals/Objectives
Marijuana Kirk Carruthers, MD Assistant Professor - Clinical Department of Psychiatry The Ohio State University Wexner Medical Center Marijuana (Cannabis Use Disorder) Learning Goals/Objectives Discuss
More informationDSM5: How to Understand It and How to Help
DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental
More informationSUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
More informationConsumer Information Cannabis (Marihuana, marijuana)
Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationComorbidity of Substance Use Disorders and Psychiatric Conditions-2
Comorbidity of Substance Use Disorders and Psychiatric Conditions-2 J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens,
More informationPsychopathology Psychopathy (con t) Psychopathy Characteristics High impulsivity Thrill seeking Low empathy Low anxiety What is the common factor? Callous Self-Centeredness N M P Dr. Robert Hare
More informationMood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland
Mood Disorders Workshop 2010 Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Goals To learn about the clinical presentation of mood
More informationIntroduction to the DSM-5 for APRNs. Presenters. Disclosures. Continuing Education Subcommittee APNA Education Council. Co-Chairs of CE subcommittee:
Introduction to the DSM-5 for APRNs Continuing Education Subcommittee APNA Education Council Presenters Co-Chairs of CE subcommittee: Barbara J. Limandri, PhD, PMHCNS-BC Joyce M. Shea, DNSc, APRN, BC Presenters:
More informationDSM-5 Table of Contents
DSM-5 Table of Contents DSM-5 Classification Preface Section I: DSM-5 Basics Introduction Use of DSM-5 Cautionary Statement for Forensic Use of DSM-5 Section II: Essential Elements: Diagnostic Criteria
More informationUnderstanding Mental Illness A Review of the Disorders
Understanding Mental Illness A Review of the Disorders Objectives Define and describe mental illness To be able to recognize signs, symptoms, and behaviors of the major categories of mental illness Recognition
More informationBasics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR
Basics of Benzodiazepine Use Disorder DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members
More informationMedications For Alcohol Use Disorder
Medications For Alcohol Use Disorder PRESENTED BY: Alann Weissman-Ward, MD, Addiction Medicine fellow June 19, 2018 DISCLOSURES Speaker: Alann Weissman-Ward, MD, has nothing to disclose. Planning Committee:
More informationMarijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM
Marijuana DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee
More information_._ L.---l Alcohol Use Disorder'': b (490) Speciftj current severity: (FiO.10) Mild (F10.20) (1=10.20)
DSM-5 Classification xxv Substance-Related - - -- and Addictive.".: Disorders -- (481) The following specifiers and note apply to Substance-Related and Addictive Disorders where indicated: aspecify if:
More informationWelcome! Today we ll discuss some of the important relationships between mental and physical health that clinicians may encounter as they apply the
Welcome! Today we ll discuss some of the important relationships between mental and physical health that clinicians may encounter as they apply the SBIRT process in practice. 1 We ll start by considering
More informationTrends, Tactics and Toxicity: Marijuana Movement on Missouri College Campuses. Janice Putnam PhD, RN Amy Kiger MS, ABD Kelly Skinner DNP, FNP-C
Trends, Tactics and Toxicity: Marijuana Movement on Missouri College Campuses Janice Putnam PhD, RN Amy Kiger MS, ABD Kelly Skinner DNP, FNP-C 1 Marijuana/Cannabis Marijuana use is growing in popularity
More informationClass Objectives. Depressive Disorders 10/7/2013. Chapter 7. Depressive Disorders. Next Class:
Chapter 7 Class Objectives Depressive Disorders - Major Depressive Disorder - Persistent Depressive Disorder - Disruptive Mood Dysregulation Disorder - Premenstrual Dysphoric Disorder (PMDD) Next Class:
More informationMental Health Disorder Prevalence among Active Duty Service Members in the Military Health System, Fiscal Years
Mental Health Disorder Prevalence among Active Duty Service Members in the Military Health System, Fiscal Years 2005 2016 Prepared by the Deployment Health Clinical Center Released January 2017 by Deployment
More informationBasics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR
Basics of Benzodiazepine Use Disorder DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members
More informationINDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Division of Mental Health and Addiction (DMHA) Behavioral and Primary Healthcare Coordination (BPHC) Codes Note: Due to possible changes in Indiana
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationMental Health Issues and Treatment
Mental Health Issues and Treatment Mental health in older age Depression Causes of depression Effects of depression Suicide Newsom, Winter 2017, Psy 462/562 Psychology of Adult Development and Aging 1
More informationDepression Management
Depression Management Ulka Agarwal, M.D. Adjunct Psychiatrist Pine Rest Christian Mental Health Disclosures The presenter and all planners of this education activity do not have a financial/arrangement
More informationMethamphetamine Abuse During Pregnancy
Methamphetamine Abuse During Pregnancy Robert Davis, MD / r.w.davismd@gmail.com ❶ Statistics ❷ Pregnancy Concerns ❸ Postpartum Concerns ❹ Basic Science ❺ Best Practice Guidelines ❻ Withdrawal ❼ Recovery
More informationPsychosis, Mood, and Personality: A Clinical Perspective
Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco
More informationDelirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us
Delirium Information for patients and relatives Delirium is common Delirium is treatable Relatives can stay to help us What is delirium? Delirium is caused by a disturbance of brain function. It is used
More informationIntro to Concurrent Disorders
CSAM-SCAM Fundamentals Intro to Concurrent Disorders Presentation provided by Jennifer Brasch, MD, FRCPC Psychiatrist, Concurrent Disorders Program, St. Joseph s Healthcare There are all kinds of addicts,
More informationINDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Medicaid Rehabilitation Option (MRO) Services Codes Note: Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding
More informationThe National Methamphetamine Symposium
The National Methamphetamine Symposium Making Research Work in Practice 12 May 2015 Arts Centre, Melbourne Physical and psychological effects of methamphetamine use Amanda Baker PhD National Centre for
More informationTerminology. ECA Study. Studies on Co morbidity Most widely cited studies: Dual dx MICA CAMI Co Morbid Disorders Co Occurring Disorders
Psychiatric Co Morbidities Jeffrey Selzer, MD, FASAM Associate Professor of Psychiatry Hofstra North Shore LIJ School of Medicine Albert Einstein College of Medicine Medical Director, NYS Committee for
More informationAccurate Diagnosis of Primary Psychotic Disorders
Accurate Diagnosis of Primary Psychotic Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abuse sleep physiology effects of, 880 882 substance, in adolescents, sleep problems and, 929 946. See also Substance use and abuse, in adolescents,
More informationPerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management. AD ICD-10-CM Frequently Asked Questions
Provider Notice To: From: PerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management Date: April 23, 2015 Subject: AD 15 105 ICD-10-CM Frequently Asked Questions The Centers
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationMarijuana in the Obstetric Population
Marijuana in the Obstetric Population Brittany MacGregor PGY 1 on behalf of Sophia Lenson PGY 3, Queens OB/Gyn Objectives 1. Review the status of legalization of cannabis products in Canada and the potential
More informationPsychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic
More informationA HELPFUL WALK THROUGH DSM-5
A HELPFUL WALK THROUGH DSM-5 ROGER SHAFER, MD UNITY POINT-FINLEY SUMMIT CENTER FOR OLDER ADULTS DUBUQUE, IA OBJECTIVES The learner will identify the foundational differences between the DSM-5 and the previous
More informationToday s Presenter 4/22/2015. ICD-10-CM Documentation and Diagnosis: Behavioral Health. By Tammy Jones, CPC, COC
ICD-10-CM Documentation and Diagnosis: Behavioral Health By Tammy Jones, CPC, COC Today s Presenter Tammy Jones, CPC, COC SVA Healthcare Services, LLC 608.826.2147 jonest@sva.com 1 ICD-10 Documentation
More informationKey Issues in Child Welfare: Behavioral Health (abridged elearning Storyboard)
Key Issues in Child Welfare: Behavioral Health (abridged elearning Storyboard) We ve covered the key issues of substance use disorders and intimate partner violence. Let s talk now about behavioral health.
More informationCASE 5 - Toy & Klamen CASE FILES: Psychiatry
CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The
More informationAgoraphobia. An anxiety disorder marked by fear of being in situations in which escape may be difficult or impossible.
Agoraphobia An anxiety disorder marked by fear of being in situations in which escape may be difficult or impossible. (See page 634) Antisocial personality disorder (APD) A personality disorder marked
More informationSee Through The Masquerade To Avoid Paying Twice
See Through The Masquerade To Avoid Paying Twice Vladimir Bokarius, MD, PhD, QME CWCDAA Conference, October, 2018 Las Vegas, NV Agenda Mental Health Mental or Medical? Mental Health Disorders Due to General
More informationDepression among Older Adults. Prevalence & Intervention Strategies
Depression among Older Adults Prevalence & Intervention Strategies Definition Depression is a complex syndrome complex characterized by mood disturbance plus variety of cognitive, psychological, and vegetative
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationDSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)
SUPPLEMENT 2 RELEVANT EXTRACTS FROM DSM-5 The following summarizes the neurocognitive disorders in DSM-5. For the complete DSM-5 see Diagnostic and Statistical Manualof Mental Disorders, 5th edn. 2013,
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationDEMOGRAPHICS. Old Age for DD. Dual Diagnosis: Mental Illness & Developmental Disabilities. Peggy A. Szwabo, Ph.D. 314/647/4488
Dual Diagnosis: Mental Illness & Developmental Disabilities Peggy A. Szwabo, Ph.D. 314/647/4488 pszwabo@sbcglobal.net DEMOGRAPHICS 10-15% of DD are 65+ 40-70% mental disorder 40% not in formal delivery
More informationZopiclone Orion. Date: , Version 1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN
Zopiclone Orion Date: 16-11-2016, Version 1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Insomnia (i.e. sleeplessness) is a common
More informationCrisis Management. Crisis Management Goals. Emotionally Disturbed Persons 10/29/2009
Crisis Management Crisis Management Goals try to ensure safety for yourself, other officers, subjects, and other citizens establish and maintain control resolve the situation positively when appropriate,
More informationDepressive and Bipolar Disorders
Depressive and Bipolar Disorders Symptoms Associated with Depressive and Bipolar Disorders Characteristics of mood symptoms Affects a person s well being, school, work, or social functioning Continues
More informationPost-Traumatic Stress Disorder (PTSD) Among People Living with HIV
Post-Traumatic Stress Disorder (PTSD) Among People Living with HIV Milton L. Wainberg, M.D. Associate Clinical Professor of Psychiatry College of Physicians and Surgeons Columbia University mlw35@columbia.edu
More informationAdolescents And Addiction
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
More informationTOOL 1: QUESTIONS BY ASAM DIMENSIONS
TOOL 1: QUESTIONS BY ASAM DIMENSIONS The following tool highlights specific questions that should be asked of the patient for each ASAM dimension. Name Date of Birth Date of Interview Address Referred
More informationOffice Practice Coding Assistance - Overview
Office Practice Coding Assistance - Overview Three office coding assistance resources are provided in the STABLE Resource Toolkit. Depression & Bipolar Coding Reference: n Provides ICD9CM and DSM-IV-TR
More informationSubstance use and perceived symptom improvement among patients with bipolar disorder and substance dependence
Journal of Affective Disorders 79 (2004) 279 283 Brief report Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence Roger D. Weiss a,b, *, Monika
More information1 STUDYING THE STUDY DRUG: ADDERALL. iaddiction.com
1 STUDYING THE STUDY DRUG: ADDERALL Societal Impact of the Drug A stimulant often prescribed for attention deficit hyperactivity disorder (ADHD) and narcolepsy, Adderall has become a drug of choice for
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationProfile of PAES Recipients and Factors That Influence PAES Outcomes
` San Francisco Department of Human Services County Adult Assistance Programs Personal Assisted Employment Services Program Profile of PAES Recipients and Factors That Influence PAES Outcomes Analysis
More informationTHE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at sandymorgenthal@yahoo.com
More informationResidual Functional Capacity Questionnaire MENTAL IMPAIRMENT
Residual Functional Capacity Questionnaire MENTAL IMPAIRMENT Patient: DOB: Physician completing this form: Please complete the following questions regarding this patient's impairments and attach all supporting
More informationPSYCHOLOGY. Chapter 15 PSYCHOLOGICAL DISORDERS. Chaffey College Summer 2018 Professor Trujillo
PSYCHOLOGY Chapter 15 PSYCHOLOGICAL DISORDERS Chaffey College Summer 2018 Professor Trujillo 15.1 WHAT ARE PSYCHOLOGICAL DISORDERS? A psychological disorder is a condition characterized by abnormal thoughts,
More informationAlcohol And Mood Disorders. L.E. Smit, MD, FRCPC. Objectives. February 8, 2007
Alcohol And Mood Disorders L.E. Smit, MD, FRCPC February 8, 2007 1 Objectives To provide an overview of mood and anxiety disorders and alcohol use disorders. Their prevalence co-morbidity and treatment.
More informationSubstance Induced Disorders
Substance Induced Disorders Julie Kmiec, DO University of Pittsburgh AOAAM 2018 Objectives At the end of this lecture, participants should be able to: Understand the difference between substance induced
More informationAdolescents And Addiction
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
More informationDepartment of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT
Department of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT The purpose of this report is to outline the information needed to make a disability determination. This is not a required format; however,
More informationSubstance Abuse Protracted Withdrawal
Substance Abuse Protracted Withdrawal Overview 1. Acute and Protracted Withdrawal 2. Withdrawal Potential Kate Speck, PhD, MAC, LADC 3. Recovery Reinforcers 1 2 3 Addiction Addiction is a primary, chronic,
More informationENTITLEMENT ELIGIBILITY GUIDELINE POSTTRAUMATIC STRESS DISORDER
ENTITLEMENT ELIGIBILITY GUIDELINE POSTTRAUMATIC STRESS DISORDER MPC 00620 ICD-9 309.81 ICD-10 43.1 DEFINITION Posttraumatic Stress Disorder (PTSD) is a condition in the Diagnostic and Statistical Manual
More informationPsychotropic Drugs 0, 4-
0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID
More informationDefining Mental Disorders. Judy Bass, MPH, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More information4/29/2015. Dr. Carman Gill Wednesday, April 29th
Dr. Carman Gill Wednesday, April 29th 1 Impacted diagnoses Major changes and rationale Special considerations Implications for counselors A sustained condition of prolonged emotional dejection, sadness,
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationBAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:
More informationBroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders
BroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders BRIAN PALMER: Hi. My name is Brian Palmer. I'm a psychiatrist here at Mayo Clinic. Today, we'd like
More informationCMASA 2016 Stellenbosch. Dr David Swingler 02 June Acknowledgements
CMASA 2016 Stellenbosch Dr David Swingler 02 June 2016 Acknowledgements DSM-5 History & development What s new Concepts Overview A speed-dating surf through the disorders With particular reference to conditions
More information4. General overview Definition
4. General overview 4.1. Definition Schizophrenia is a severe psychotic mental disorder characterized by significant disturbances of mental functioning. It has also been called early dementia, intrapsychic
More information